Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Tumor necrosis factor receptor superfamily member 11b (TNFRSF11B) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the messenger RNA that encodes osteoprotegerin (OPG) [PMID: 9144294]. OPG serves as a secreted decoy receptor for the Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL), effectively preventing RANKL from binding to its receptor RANK on osteoclast precursors, which inhibits bone resorption [PMID: 10359812]. The 3'-UTR contains specific sequences that serve as binding sites for microRNAs (miRNAs) and RNA-binding proteins, which post-transcriptionally control OPG expression by modulating mRNA stability and translation [PMID: 25650543]. Dysregulation of this regulatory region is linked to various pathologies, including osteoporosis, Paget's disease of bone, and vascular calcification, where the balance between bone formation and resorption is disrupted [PMID: 15355921]. While no drugs targeting this specific mRNA region are currently approved for clinical use, it is an active area of research for RNA-based therapeutics, such as antisense oligonucleotides and miRNA mimics, aimed at restoring OPG levels to treat metabolic bone disorders [PMID: 30639594].
Modulation of mRNA stability and translation through sequence-specific binding of RNA-targeting agents to regulate osteoprotegerin protein synthesis.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor necrosis factor receptor superfamily member 11b mRNA 3'-untranslated region (TNFRSF11B mRNA 3'-UTR).